Michael Davis becomes Cyanotech chairman

Hawaiian microalgae technology company looks forward to continuing support of its major shareholder

Michael Davis has been elected as chairman of Hawaii-based Cyanotech Corporation. He replaces Gregg Robertson, who resigned in late 2010.

Davis was vice-chairman of the board and has been a director of Cyanotech since March 2003.

‘Michael has been a key influence in helping Cyanotech sharpen its business model and market focus in recent years,’ said Brent Bailey, president and ceo. ‘We look forward to his continuing support and leadership as chairman of the board.’

Cyanotech Corporation, a microalgae technology specialist, produces BioAstin Natural Astaxanthin and Hawaiian Spirulina Pacifica, which are natural, functional nutrients.

You may also like

Ingredients

dsm-firmenich launches ModulaSENSE Bitter to tackle bitterness in oral drug formulations

The new taste modulation technology combines bitter blockers, maskers and sweeteners with receptor-based analysis to help pharmaceutical formulators improve the palatability of oral medicines
Manufacturing

Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas

Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
Ingredients

Sequential extraction kit enables multiomics analysis from a single sample

Thermo Fisher Scientific launches a magnetic bead-based workflow to support genomic, transcriptomic and proteomic research
Ingredients

Echo MS+ integration enhances high-throughput mass spectrometry

SCIEX expands compatibility with the ZenoTOF 8600 system to deliver greater sensitivity and automation capabilities
Manufacturing

IMA strengthens aseptic and containment capabilities with ProSys acquisition

The deal expands IMA’s isolator and sampling technology portfolio for the global biopharmaceutical market
Ingredients

Lighthouse photoreactor module expands Integrity 10 platform for controlled, high-throughput photochemistry

New module enables parallel photochemistry with precise reaction control and flexible LED options
Ingredients

Promega unveils cellular target engagement technology

TarSeer BRETSA platform enables early-stage studies for difficult proteins in drug discovery
Subscribe now